The HPV Vaccines—Which to Prefer? : Obstetrical & Gynecological Survey The HPV
Vaccines—Which to Prefer? : Obstetrical & Gynecological Survey Log in or Register Subscribe …

A subset of human papillomaviruses (HPVs) promote anogenital malignancy, including
cervical cancer, and prevention and treatment strategies that reflect the causal role of HPV …

Human papillomavirus (HPV) vaccines, which were introduced in many countries in the past
decade, have shown promising results in decreasing HPV infection and related diseases …

With the approval of Gardasil®(Merck and Co., Inc., Whitehouse Station, NJ) in June of 2006
and the pending approval of Cervarix®(GlaxoSmithKline, London, UK), two prophylactic …

Human papillomavirus (HPV) infections of cutaneous and genital mucosae are very
common but the majority of individuals clear the infection without overt clinical disease …

Human papillomaviruses (HPV) are a large group of viruses (more than 200 types identified)
that infect the epithelium of the skin and mucous membranes. The infections can be latent …

Human papillomavirus (HPV) infection causes virtually all cases of cervical cancer, the
second most common cause of death from cancer among women worldwide. This Review …

Abstract Learning Objectives After completing this course, the reader will be able to: Discuss
the epidemiology and pathogenesis of HPV and HPV-associated diseases. Explain the …

Routine vaccination programs have had a substantial impact on reducing the prevalence of
a variety of infectious diseases. In light of the fact that human papillomavirus (HPV) is a …

Abstract Background. A quadrivalent (types 6, 11, 16, and 18) human papillomavirus (HPV)
L1 virus-like-particle (VLP) vaccine has been shown to be 95%–100% effective in …